Comparison of Accelerated Hyperfractionated Radiotherapy and Conventional Radiotherapy for Supratentorial Malignant Glioma

Japanese Journal of Clinical Oncology

Volumn 27, Issue 1, 1997, Pages 31-36

  Shibamoto, Yuta ^a,b   Nishimura, Yasumasa ^b   Tsutsui, Kazushige ^c   Sasai, Keisuke ^b   Takahashi, Masaji ^a,b   Abe, Mitsuyuki ^b  

^a Chest Disease Research Institute   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c JAPANESE RED CROSS WAKAYAMA MEDICAL CENTER   (Japan)

Author keywords

Accelerated hyperfractionation; Brain neoplasm; Interferon; Malignant glioma; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT; BETA INTERFERON; NIMUSTINE;

ADULT; ARTICLE; BRAIN TUMOR; COMPARATIVE STUDY; FEMALE; GLIOMA; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PROGNOSIS; RADIATION DOSE; SURVIVAL RATE;

ADULT; ANTINEOPLASTIC AGENTS; FEMALE; GLIOMA; HUMANS; INTERFERON-BETA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NIMUSTINE; PROGNOSIS; RADIOTHERAPY DOSAGE; SUPRATENTORIAL NEOPLASMS; SURVIVAL RATE;

EID: 0031066299     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/27.1.31     Document Type: Article

References (33)

1. Chang CH, Horton J, Schoenfeld D, Salazar O, Perez-Tamayo R, Kramer S et al. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemothorapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 1983;52:997-1007.
2. Burger PC, Vogel FS, Green SB, Strike TA: Glioblastoma and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 1985;56:1106-11.
3. Shibamoto Y, Yamashita J, Takahashi M, Yamasaki T, Kikuchi H, Abe M. Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases Radiother Oncol 1990;18:9-17.
4. The Committee of Brain Tumor Registry of Japan. Brain Tumor Registry of Japan 8, National Cancer Center, Tokyo, 1993 (in Japanese)
5. Takakura K, Abe H, Tanaka R, Kitamura K, Miwa T, Takeuchi K et al. Effects of ACNU and radiotherapy on malignant glioma. J Neurosurg 1986;64:53-7.
6. Withers HR: Biologic basis for altered fractionation schemes. Cancer 1985;55:2086-95.
7. Nelson DF, Curran WJ, Scott C, Weinstein AS, Ahmad K, Constine LS et al. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma - possible advantage observed at 72.0 Gy in 1.2 Gy b i.d. fractions: report of the Radiation Therapy Oncology Group Protocol 8302. Int J Radiat Oncol Biol Phys 1993;25:193-207.
8. Hoshino T, Wilson CB: Cell kinetic analyses of human malignant brain tumors (gliomas). Cancer 1979;44:956-62.
9. Hoshino T, Ito S, Asai A, Shibuya M, Prados MD, Dodson BA et al. Cell kinetic analysis of human brain tumors by in situ double labelling with bromodeoxyuridine and iododeoxyundine. Int J Cancer 1992;50:1-5.
10. Marks JE, Baglan RJ, Prassad SC, Blank WF: Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. Int J Radiat Oncol Biol Phys 1981;7:243-52.
11. Takagi H. Multiple regression analysis. In: Handbook of Multivariate Analysis, Yanai H, Takagi H, editors. Kyoto: Gendaisuugakusha 1993;18 69. (in Japanese)
12. Shin KH, Urtasun RC, Fulton D, Geggie PHS, Tanasichuk H, Thomas H et al Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report. Cancer 1985;56:758-60.
13. Simpson WJ, Platts ME: Fractionation study in the treatment of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1976;1:639-44.
14. Payne DG, Simpson WJ, Keen C, Platts ME. Malignant astrocytoma. Hyperfractionated and Standard radiotherapy with chemotherapy in a randomized prospective clinicl trial. Cancer 1982;50 2301-06.
15. Ludgate CM, Douglas BG, Dixon PF, Steinbok P, Jackson SM, Goodman GB: Superfractionated radiotherapy in Grade III, IV intracranial gliomas. Int J Radiat Oncol Biol Phys 1988;15:1091-95.
16. Keirn H, Potthoff PC, Schmidt K, Schiebusch M, Neiss A, Trott KR: Survival and quality of life after continuous accelerated radiotherapy of glioblastomas. Radiother Oncol 1987,9.21-6.
17. Gonzalez Gonzalez D, Menten J, Bosch DA, van der Schueren E, Troost D, Hulshof MCCM et al. Accelerated radiotherapy in glioblastoma multiforme: a dose searching prospective study. Radiother Oncol 1994;32:98-105.
18. Brada M, Thomas G, Elyan S, James N, Hines F, Ashley S et al. Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma. Br J Cancer 71, 1330-4, 1995
19. Bignardi M, Bertoni F: Radiation treatment with twice a day fractionation versus conventional fractionation in high grade astrocytoma. Acta Oncol 1987;26:441-5.
20. Walker MD, Strike TA, Sheline GE: An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979;5 1725-31.
21. Fowler JF: The linear-quadratic formula and progress in fractionated radiotherapy Br J Radiol 1989;62:679-94.
22. Raaphorst GP, Feeley MM, Da Silva VF, Danjoux CE, Gerig LH: A comparison of heat and radiation sensitivity of three human glioma cell lines. Int J Radiat Oncol Biol Phys 1989,17:615-22.
23. Yang X, Darling JL, McMillan TJ, Peacock JH, Steel GG: Radiosensitivity, recovery and dose-rate effect in three human glioma cell lines. Radiother Oncol 1990,19:49-56
24. Assietti R, Butti G, Magrassi L, Danova M, Riccardi A, Gaetani P: Cell-kinetic characteristics of human brain tumors. Oncology 1990; 47:344-51.
25. Shibamoto Y, Streffer C. Estimation of the dividing fraction and potential doubling time of tumors using cytochalasin B. Cancer Res 51: 5134-8, 1991
26. Shibamoto Y, Shibata T, Miyatake S, Oda Y, Manabe T, Ohshio G et al. Assessment of the proliferative activity and radiosensitivity of human tumours using the cytokinesis-block micronucleus assay. Br J Cancer 1994, 70:67-71.
27. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 1993;26:239-44.
28. Jeremic B, Grujicic D, Antunovic V, Djuric L, Shibamoto Y: Accelerated hyperfractionated radiation therapy for malignant glioma. A phase II study. Am J Clin Oncol 1995;18:449-53.
29. Nagai M: Interferon therapy: glioma. Rinsho-1 1993;19:1514-8. (in Japanese)
30. Yoshida J, Kajita Y, Wakabayashi T, Sugita K: Long-term follow-up results of 175 patients with malignant glioma: importance of radical tumour resection and postoperative adjuvant therapy with Interferon, ACNU and radiation. Acta Neurochir 1994;127.55-9.
31. Mahaley MS Jr, Dropcho EJ, Bertsch L, Tirey T, Gillespie GY: Systemic beta-interferon therapy for recurrent gliomas: a brief report. J Neurosurg 1989, 71:639-41.
32. Jerob B, Petric-Grabnar G, Klun B, Lamovec J, Skrbec M, Soos E: Addition of IFN-α to treatment of malignant brain tumors. Acta Oncol 1994;33:651-4.
33. Hagberg H, Blomkvist E, Ponten U, Persson L, Muhr C, Eriksson B et al. Does alpha-interferon in conjunction with radiotherapy increase the risk of complications in the central nervous system? Ann Oncol 1990,1:449.